Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Jan;36(1):48-52.
doi: 10.1007/s00259-008-0944-5. Epub 2008 Sep 20.

Correlation of immunohistopathological expression of somatostatin receptor 2 with standardised uptake values in 68Ga-DOTATOC PET/CT

Affiliations
Free article

Correlation of immunohistopathological expression of somatostatin receptor 2 with standardised uptake values in 68Ga-DOTATOC PET/CT

Matthias Miederer et al. Eur J Nucl Med Mol Imaging. 2009 Jan.
Free article

Abstract

Purpose: In clinical routine somatostatin analogue positron emission tomography/computed tomography (PET/CT) such as (68)Ga-DOTA-Tyr-octreotide (DOTATOC)-PET/CT could substitute conventional (111)In-Octreotide scintigraphy. Immunohistochemistry (IHC) for somatostatin receptor 2 (SSTR2) might be a tool to predict positivity of (68)Ga-DOTATOC in patients where initial staging was not performed, e.g., in incidental findings. We therefore compared a score of SSTR2-IHC with the in vivo standard uptake value (SUV) of preoperative or prebiopsy (68)Ga-DOTATOC PET/CT.

Materials and methods: In 18 patients, (68)Ga-DOTATOC PET/CT scans were quantified with SUV calculations and correlated to a cell membrane-based SSTR2-IHC score (ranging from 0 to 3).

Results: Negative IHC scores were consistent with SUV values below 10. Furthermore, all score 2 and 3 specimens corresponded with high SUV values (above 15).

Conclusion: SSTR2-IHC scores correlated well with SUV values and we propose to use SSTR2 immunohistochemistry in patients missing a preoperative PET scan to indicate (68)Ga-DOTATOC-PET/CT as method for restaging and follow-up in individual patients.

PubMed Disclaimer

References

    1. Eur J Nucl Med Mol Imaging. 2007 Oct;34(10 ):1617-26 - PubMed
    1. J Nucl Med. 2005 Jan;46 Suppl 1:76S-82S - PubMed
    1. J Clin Oncol. 2008 Feb 20;26(6):963-70 - PubMed
    1. Mod Pathol. 2007 Nov;20(11):1172-82 - PubMed
    1. Eur Radiol. 1997;7(7):1103-9 - PubMed

MeSH terms